Oral Ketamine vs Placebo in Patients With Cancer-Related Neuropathic Pain: A Randomized Clinical Trial
Year: 2018
Type: article
Study design: Clinical Trial
Abstract: Randomized Clinical TrialKetamine hydrochloride is used as an adjuvant treatment for cancer-related neuropathic pain, but evidence of its effectiveness is limited. 1 Findings of a large trial investigating the use of ketamine for general cancer pain were negative, but the population studied did not specifically have neuropathic pain. 2 A randomized trial of oral ketamine for cancer-related neuropathic pain has been called for, 3 and the present trial addresses that need.
Source: JAMA Oncology
Language: English
Subfield: Anesthesiology and Pain Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $5,342
Awards: G4991785069, G7984755422
OpenAlex ID: W2796228561
